+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biodefense Market - Global Forecast 2026-2032- Product Image
Biodefense Market - Global Forecast 2026-2032- Product Image
New

Biodefense Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 180 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 6082678
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Senior executives require clear foresight and agility when responding to the complexities of the biodefense landscape. With converging health and security threats demanding scalable resilience, the biodefense market has become a cornerstone for organizations positioning themselves at the forefront of prevention, detection, and integrated response.

Market Snapshot: Biodefense Market Size and Growth Trajectory

The biodefense market demonstrates strong, sustained growth, advancing from USD 22.71 billion in 2025 to USD 24.97 billion in 2026, and is forecast to reach USD 49.09 billion by 2032. Powered by a compound annual growth rate of 11.64%, this trajectory highlights surging investment in adaptable countermeasures, robust supply chain fortification, and cross-sector health security systems. The expansion is driven by an increasing awareness of emerging biological risks and the strategic need for high-impact solutions that enable timely mitigation.

Scope & Segmentation of the Biodefense Market

  • Product Types: Decontamination solutions encompass advanced disinfectants and personal protective equipment tailored for high-containment environments. Detection platforms integrate rapid biosensors and specialized laboratory systems, addressing varied operational needs. Therapeutic agents, including antiviral drugs and monoclonal antibodies, enable precise and targeted interventions. Vaccines are developed for a spectrum of disease threats, ensuring comprehensive protection strategies across population segments.
  • Pathogen Targets: Solutions are designed to confront bacterial agents, toxin threats, and viral pathogens; each category requires unique clinical and operational countermeasures to ensure efficacy and containment.
  • Technologies: Immunoassays, PCR-based diagnostics, mass spectrometry, and next generation sequencing enhance detection, inform clinical decision-making, and optimize surveillance at scale.
  • Applications: Encompassing detection, diagnostics, prevention through vaccination or decontamination, and tailored clinical treatment, the market addresses both acute outbreak and chronic biosecurity challenges.
  • End Users: Academic and research institutes, government organizations, defense and security agencies, hospitals, clinics, pharmaceutical developers, and biotechnology enterprises are key participants, each contributing distinct expertise and infrastructure.
  • Distribution Channels: Offline routes leverage specialized laboratory suppliers and technical consultancies to ensure quality and compliance, while online platforms—such as e-commerce partners and automated inventory systems—improve accessibility and supply reliability.
  • Regions: Americas, Europe Middle East & Africa, and Asia-Pacific each possess distinct regulatory standards, funding frameworks, and response networks that shape market adoption and innovation priorities.

Key Takeaways for Senior Decision-Makers

  • Integrated frameworks unite government, research, healthcare, and private industry to bridge public health and security objectives in the biodefense ecosystem.
  • Advanced technologies—ranging from AI-driven surveillance to molecular diagnostics—are reshaping early threat identification and accelerating incident response times.
  • International collaboration across borders supports joint procurement, shared research, and coordinated operational readiness, establishing a unified defense against biosecurity risks.
  • Localized manufacturing and resilient supply networks are minimizing disruptions resulting from shifting policy mandates, particularly in response to trade constraints and tariffs.
  • Public-private partnerships play a pivotal role in transitioning new solutions rapidly from concept to application, ensuring effective scaling across diverse settings.
  • Niche and mid-tier providers are increasingly vital, enabling agile manufacturing and specialized testing for both established organizations and innovative market entrants.

Tariff Impact: Supply Chain Localization and Strategic Sourcing

Recent shifts in U.S. tariff policy affecting biotechnology imports have motivated market participants to expand domestic production and broaden sourcing strategies. Companies are enhancing in-country manufacturing capacity for critical reagents like polymerase chain reaction materials, monoclonal antibodies, and vaccine inputs. This regional emphasis improves continuity in procurement, strengthens compliance with national security objectives, and shortens turnaround times for essential resources.

Comprehensive Market Methodology & Data Sources

This market intelligence is grounded in a rigorous mixed-methods approach. It combines primary interviews with senior sector stakeholders, a thorough review of secondary datasets, and iterative validation with recognized domain experts. Granular segmentation mapping delivers targeted analysis of products, applications, technologies, and supply chain dynamics.

Why This Biodefense Market Report Matters

  • Enables informed strategy and procurement decisions by equipping organizations with insights into evolving technologies, competitor moves, and geographic focus areas.
  • Assists in optimizing supply networks, helping future-proof operational workflows against evolving global and local regulatory pressures on biosecurity.
  • Provides actionable guidance for executives to anticipate new risks and leverage collaborative, cross-sector pathways within a rapidly transforming landscape.

Conclusion

The dynamic biodefense market requires organizations to adapt quickly, incorporating technology, strengthening alliances, and aligning with advancing policy requirements. This report offers decision-makers the analysis necessary to secure effective, resilient positions within the biosecurity and health preparedness arena.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Biodefense Market, by Product Type
8.1. Decontamination Products
8.1.1. Disinfectants
8.1.2. PPE
8.2. Detection Devices
8.2.1. Biosensors
8.2.2. Pathogen Detection Systems
8.3. Therapeutics
8.3.1. Antiviral Therapies
8.3.2. Monoclonal Antibodies
8.4. Vaccines
8.4.1. Anthrax Vaccine
8.4.2. Botulism Vaccine
8.4.3. Smallpox Vaccine
9. Biodefense Market, by Pathogen Type
9.1. Bacterial Agents
9.2. Toxins
9.3. Viral Agents
10. Biodefense Market, by Technology
10.1. Immunoassays
10.2. Mass Spectrometry
10.3. Next Generation Sequencing
10.4. Polymerase Chain Reaction
11. Biodefense Market, by Application
11.1. Detection & Diagnostics
11.2. Prevention
11.3. Treatment
12. Biodefense Market, by End User
12.1. Academic & Research Institutes
12.2. Government & Defense Agencies
12.3. Hospitals & Clinics
12.4. Pharma & Biotech Companies
13. Biodefense Market, by Distribution Channel
13.1. Offline Channels
13.2. Online Channels
14. Biodefense Market, by Region
14.1. Americas
14.1.1. North America
14.1.2. Latin America
14.2. Europe, Middle East & Africa
14.2.1. Europe
14.2.2. Middle East
14.2.3. Africa
14.3. Asia-Pacific
15. Biodefense Market, by Group
15.1. ASEAN
15.2. GCC
15.3. European Union
15.4. BRICS
15.5. G7
15.6. NATO
16. Biodefense Market, by Country
16.1. United States
16.2. Canada
16.3. Mexico
16.4. Brazil
16.5. United Kingdom
16.6. Germany
16.7. France
16.8. Russia
16.9. Italy
16.10. Spain
16.11. China
16.12. India
16.13. Japan
16.14. Australia
16.15. South Korea
17. United States Biodefense Market
18. China Biodefense Market
19. Competitive Landscape
19.1. Market Concentration Analysis, 2025
19.1.1. Concentration Ratio (CR)
19.1.2. Herfindahl Hirschman Index (HHI)
19.2. Recent Developments & Impact Analysis, 2025
19.3. Product Portfolio Analysis, 2025
19.4. Benchmarking Analysis, 2025
19.5. Abbott Laboratories
19.6. Alnylam Pharmaceuticals, Inc.
19.7. Altimmune, Inc.
19.8. Bavarian Nordic A/S
19.9. Bio-Rad Laboratories
19.10. Biofourmis Singapore Pte. Ltd.
19.11. Cleveland Biolabs Inc.
19.12. Dynavax Technologies Corporation
19.13. DynPort Vaccine Company LLC
19.14. Ecolab Inc.
19.15. Elusys Therapeutics, Inc.
19.16. Emergent BioSolutions Inc.
19.17. Ichor Medical Systems
19.18. Lucentix SA
19.19. Luminex Corporation
19.20. Nova Biomedical Corporation
19.21. QIAGEN N.V.
19.22. SD BIOSENSOR
19.23. Siemens Healthcare
19.24. Siga Technologies, Inc.
19.25. Strados Labs
19.26. Thermo Fisher Scientific
19.27. Xoma Corporation
List of Figures
FIGURE 1. GLOBAL BIODEFENSE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL BIODEFENSE MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL BIODEFENSE MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL BIODEFENSE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL BIODEFENSE MARKET SIZE, BY PATHOGEN TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL BIODEFENSE MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL BIODEFENSE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL BIODEFENSE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL BIODEFENSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL BIODEFENSE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL BIODEFENSE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL BIODEFENSE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 13. UNITED STATES BIODEFENSE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 14. CHINA BIODEFENSE MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL BIODEFENSE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL BIODEFENSE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL BIODEFENSE MARKET SIZE, BY DECONTAMINATION PRODUCTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL BIODEFENSE MARKET SIZE, BY DECONTAMINATION PRODUCTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL BIODEFENSE MARKET SIZE, BY DECONTAMINATION PRODUCTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL BIODEFENSE MARKET SIZE, BY DECONTAMINATION PRODUCTS, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL BIODEFENSE MARKET SIZE, BY DISINFECTANTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL BIODEFENSE MARKET SIZE, BY DISINFECTANTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL BIODEFENSE MARKET SIZE, BY DISINFECTANTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL BIODEFENSE MARKET SIZE, BY PPE, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL BIODEFENSE MARKET SIZE, BY PPE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL BIODEFENSE MARKET SIZE, BY PPE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL BIODEFENSE MARKET SIZE, BY DETECTION DEVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL BIODEFENSE MARKET SIZE, BY DETECTION DEVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL BIODEFENSE MARKET SIZE, BY DETECTION DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL BIODEFENSE MARKET SIZE, BY DETECTION DEVICES, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL BIODEFENSE MARKET SIZE, BY BIOSENSORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL BIODEFENSE MARKET SIZE, BY BIOSENSORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL BIODEFENSE MARKET SIZE, BY BIOSENSORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL BIODEFENSE MARKET SIZE, BY PATHOGEN DETECTION SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL BIODEFENSE MARKET SIZE, BY PATHOGEN DETECTION SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL BIODEFENSE MARKET SIZE, BY PATHOGEN DETECTION SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL BIODEFENSE MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL BIODEFENSE MARKET SIZE, BY THERAPEUTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL BIODEFENSE MARKET SIZE, BY THERAPEUTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL BIODEFENSE MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL BIODEFENSE MARKET SIZE, BY ANTIVIRAL THERAPIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL BIODEFENSE MARKET SIZE, BY ANTIVIRAL THERAPIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL BIODEFENSE MARKET SIZE, BY ANTIVIRAL THERAPIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL BIODEFENSE MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL BIODEFENSE MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL BIODEFENSE MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL BIODEFENSE MARKET SIZE, BY VACCINES, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL BIODEFENSE MARKET SIZE, BY VACCINES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL BIODEFENSE MARKET SIZE, BY VACCINES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL BIODEFENSE MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL BIODEFENSE MARKET SIZE, BY ANTHRAX VACCINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL BIODEFENSE MARKET SIZE, BY ANTHRAX VACCINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL BIODEFENSE MARKET SIZE, BY ANTHRAX VACCINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL BIODEFENSE MARKET SIZE, BY BOTULISM VACCINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL BIODEFENSE MARKET SIZE, BY BOTULISM VACCINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL BIODEFENSE MARKET SIZE, BY BOTULISM VACCINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL BIODEFENSE MARKET SIZE, BY SMALLPOX VACCINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL BIODEFENSE MARKET SIZE, BY SMALLPOX VACCINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL BIODEFENSE MARKET SIZE, BY SMALLPOX VACCINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL BIODEFENSE MARKET SIZE, BY PATHOGEN TYPE, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL BIODEFENSE MARKET SIZE, BY BACTERIAL AGENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL BIODEFENSE MARKET SIZE, BY BACTERIAL AGENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL BIODEFENSE MARKET SIZE, BY BACTERIAL AGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL BIODEFENSE MARKET SIZE, BY TOXINS, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL BIODEFENSE MARKET SIZE, BY TOXINS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL BIODEFENSE MARKET SIZE, BY TOXINS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL BIODEFENSE MARKET SIZE, BY VIRAL AGENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL BIODEFENSE MARKET SIZE, BY VIRAL AGENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL BIODEFENSE MARKET SIZE, BY VIRAL AGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL BIODEFENSE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL BIODEFENSE MARKET SIZE, BY IMMUNOASSAYS, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL BIODEFENSE MARKET SIZE, BY IMMUNOASSAYS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL BIODEFENSE MARKET SIZE, BY IMMUNOASSAYS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL BIODEFENSE MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL BIODEFENSE MARKET SIZE, BY MASS SPECTROMETRY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL BIODEFENSE MARKET SIZE, BY MASS SPECTROMETRY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL BIODEFENSE MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL BIODEFENSE MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL BIODEFENSE MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL BIODEFENSE MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL BIODEFENSE MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL BIODEFENSE MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL BIODEFENSE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL BIODEFENSE MARKET SIZE, BY DETECTION & DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL BIODEFENSE MARKET SIZE, BY DETECTION & DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL BIODEFENSE MARKET SIZE, BY DETECTION & DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL BIODEFENSE MARKET SIZE, BY PREVENTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL BIODEFENSE MARKET SIZE, BY PREVENTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL BIODEFENSE MARKET SIZE, BY PREVENTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL BIODEFENSE MARKET SIZE, BY TREATMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL BIODEFENSE MARKET SIZE, BY TREATMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL BIODEFENSE MARKET SIZE, BY TREATMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL BIODEFENSE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL BIODEFENSE MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL BIODEFENSE MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL BIODEFENSE MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL BIODEFENSE MARKET SIZE, BY GOVERNMENT & DEFENSE AGENCIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL BIODEFENSE MARKET SIZE, BY GOVERNMENT & DEFENSE AGENCIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL BIODEFENSE MARKET SIZE, BY GOVERNMENT & DEFENSE AGENCIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL BIODEFENSE MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL BIODEFENSE MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL BIODEFENSE MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL BIODEFENSE MARKET SIZE, BY PHARMA & BIOTECH COMPANIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL BIODEFENSE MARKET SIZE, BY PHARMA & BIOTECH COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL BIODEFENSE MARKET SIZE, BY PHARMA & BIOTECH COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL BIODEFENSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL BIODEFENSE MARKET SIZE, BY OFFLINE CHANNELS, BY REGION, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL BIODEFENSE MARKET SIZE, BY OFFLINE CHANNELS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL BIODEFENSE MARKET SIZE, BY OFFLINE CHANNELS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL BIODEFENSE MARKET SIZE, BY ONLINE CHANNELS, BY REGION, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL BIODEFENSE MARKET SIZE, BY ONLINE CHANNELS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL BIODEFENSE MARKET SIZE, BY ONLINE CHANNELS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL BIODEFENSE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 100. AMERICAS BIODEFENSE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 101. AMERICAS BIODEFENSE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 102. AMERICAS BIODEFENSE MARKET SIZE, BY DECONTAMINATION PRODUCTS, 2018-2032 (USD MILLION)
TABLE 103. AMERICAS BIODEFENSE MARKET SIZE, BY DETECTION DEVICES, 2018-2032 (USD MILLION)
TABLE 104. AMERICAS BIODEFENSE MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 105. AMERICAS BIODEFENSE MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 106. AMERICAS BIODEFENSE MARKET SIZE, BY PATHOGEN TYPE, 2018-2032 (USD MILLION)
TABLE 107. AMERICAS BIODEFENSE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 108. AMERICAS BIODEFENSE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 109. AMERICAS BIODEFENSE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 110. AMERICAS BIODEFENSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 111. NORTH AMERICA BIODEFENSE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 112. NORTH AMERICA BIODEFENSE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 113. NORTH AMERICA BIODEFENSE MARKET SIZE, BY DECONTAMINATION PRODUCTS, 2018-2032 (USD MILLION)
TABLE 114. NORTH AMERICA BIODEFENSE MARKET SIZE, BY DETECTION DEVICES, 2018-2032 (USD MILLION)
TABLE 115. NORTH AMERICA BIODEFENSE MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 116. NORTH AMERICA BIODEFENSE MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 117. NORTH AMERICA BIODEFENSE MARKET SIZE, BY PATHOGEN TYPE, 2018-2032 (USD MILLION)
TABLE 118. NORTH AMERICA BIODEFENSE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 119. NORTH AMERICA BIODEFENSE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 120. NORTH AMERICA BIODEFENSE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 121. NORTH AMERICA BIODEFENSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 122. LATIN AMERICA BIODEFENSE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 123. LATIN AMERICA BIODEFENSE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 124. LATIN AMERICA BIODEFENSE MARKET SIZE, BY DECONTAMINATION PRODUCTS, 2018-2032 (USD MILLION)
TABLE 125. LATIN AMERICA BIODEFENSE MARKET SIZE, BY DETECTION DEVICES, 2018-2032 (USD MILLION)
TABLE 126. LATIN AMERICA BIODEFENSE MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 127. LATIN AMERICA BIODEFENSE MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 128. LATIN AMERICA BIODEFENSE MARKET SIZE, BY PATHOGEN TYPE, 2018-2032 (USD MILLION)
TABLE 129. LATIN AMERICA BIODEFENSE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 130. LATIN AMERICA BIODEFENSE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 131. LATIN AMERICA BIODEFENSE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 132. LATIN AMERICA BIODEFENSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA BIODEFENSE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA BIODEFENSE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA BIODEFENSE MARKET SIZE, BY DECONTAMINATION PRODUCTS, 2018-2032 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA BIODEFENSE MARKET SIZE, BY DETECTION DEVICES, 2018-2032 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA BIODEFENSE MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA BIODEFENSE MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA BIODEFENSE MARKET SIZE, BY PATHOGEN TYPE, 2018-2032 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA BIODEFENSE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA BIODEFENSE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA BIODEFENSE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA BIODEFENSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 144. EUROPE BIODEFENSE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 145. EUROPE BIODEFENSE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 146. EUROPE BIODEFENSE MARKET SIZE, BY DECONTAMINATION PRODUCTS, 2018-2032 (USD MILLION)
TABLE 147. EUROPE BIODEFENSE MARKET SIZE, BY DETECTION DEVICES, 2018-2032 (USD MILLION)
TABLE 148. EUROPE BIODEFENSE MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 149. EUROPE BIODEFENSE MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 150. EUROPE BIODEFENSE MARKET SIZE, BY PATHOGEN TYPE, 2018-2032 (USD MILLION)
TABLE 151. EUROPE BIODEFENSE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 152. EUROPE BIODEFENSE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 153. EUROPE BIODEFENSE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 154. EUROPE BIODEFENSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 155. MIDDLE EAST BIODEFENSE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 156. MIDDLE EAST BIODEFENSE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 157. MIDDLE EAST BIODEFENSE MARKET SIZE, BY DECONTAMINATION PRODUCTS, 2018-2032 (USD MILLION)
TABLE 158. MIDDLE EAST BIODEFENSE MARKET SIZE, BY DETECTION DEVICES, 2018-2032 (USD MILLION)
TABLE 159. MIDDLE EAST BIODEFENSE MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 160. MIDDLE EAST BIODEFENSE MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 161. MIDDLE EAST BIODEFENSE MARKET SIZE, BY PATHOGEN TYPE, 2018-2032 (USD MILLION)
TABLE 162. MIDDLE EAST BIODEFENSE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 163. MIDDLE EAST BIODEFENSE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 164. MIDDLE EAST BIODEFENSE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 165. MIDDLE EAST BIODEFENSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 166. AFRICA BIODEFENSE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 167. AFRICA BIODEFENSE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 168. AFRICA BIODEFENSE MARKET SIZE, BY DECONTAMINATION PRODUCTS, 2018-2032 (USD MILLION)
TABLE 169. AFRICA BIODEFENSE MARKET SIZE, BY DETECTION DEVICES, 2018-2032 (USD MILLION)
TABLE 170. AFRICA BIODEFENSE MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 171. AFRICA BIODEFENSE MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 172. AFRICA BIODEFENSE MARKET SIZE, BY PATHOGEN TYPE, 2018-2032 (USD MILLION)
TABLE 173. AFRICA BIODEFENSE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 174. AFRICA BIODEFENSE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 175. AFRICA BIODEFENSE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 176. AFRICA BIODEFENSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 177. ASIA-PACIFIC BIODEFENSE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 178. ASIA-PACIFIC BIODEFENSE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 179. ASIA-PACIFIC BIODEFENSE MARKET SIZE, BY DECONTAMINATION PRODUCTS, 2018-2032 (USD MILLION)
TABLE 180. ASIA-PACIFIC BIODEFENSE MARKET SIZE, BY DETECTION DEVICES, 2018-2032 (USD MILLION)
TABLE 181. ASIA-PACIFIC BIODEFENSE MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 182. ASIA-PACIFIC BIODEFENSE MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 183. ASIA-PACIFIC BIODEFENSE MARKET SIZE, BY PATHOGEN TYPE, 2018-2032 (USD MILLION)
TABLE 184. ASIA-PACIFIC BIODEFENSE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 185. ASIA-PACIFIC BIODEFENSE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 186. ASIA-PACIFIC BIODEFENSE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 187. ASIA-PACIFIC BIODEFENSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 188. GLOBAL BIODEFENSE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 189. ASEAN BIODEFENSE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 190. ASEAN BIODEFENSE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 191. ASEAN BIODEFENSE MARKET SIZE, BY DECONTAMINATION PRODUCTS, 2018-2032 (USD MILLION)
TABLE 192. ASEAN BIODEFENSE MARKET SIZE, BY DETECTION DEVICES, 2018-2032 (USD MILLION)
TABLE 193. ASEAN BIODEFENSE MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 194. ASEAN BIODEFENSE MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 195. ASEAN BIODEFENSE MARKET SIZE, BY PATHOGEN TYPE, 2018-2032 (USD MILLION)
TABLE 196. ASEAN BIODEFENSE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 197. ASEAN BIODEFENSE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 198. ASEAN BIODEFENSE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 199. ASEAN BIODEFENSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 200. GCC BIODEFENSE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 201. GCC BIODEFENSE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 202. GCC BIODEFENSE MARKET SIZE, BY DECONTAMINATION PRODUCTS, 2018-2032 (USD MILLION)
TABLE 203. GCC BIODEFENSE MARKET SIZE, BY DETECTION DEVICES, 2018-2032 (USD MILLION)
TABLE 204. GCC BIODEFENSE MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 205. GCC BIODEFENSE MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 206. GCC BIODEFENSE MARKET SIZE, BY PATHOGEN TYPE, 2018-2032 (USD MILLION)
TABLE 207. GCC BIODEFENSE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 208. GCC BIODEFENSE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 209. GCC BIODEFENSE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 210. GCC BIODEFENSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 211. EUROPEAN UNION BIODEFENSE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 212. EUROPEAN UNION BIODEFENSE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 213. EUROPEAN UNION BIODEFENSE MARKET SIZE, BY DECONTAMINATION PRODUCTS, 2018-2032 (USD MILLION)
TABLE 214. EUROPEAN UNION BIODEFENSE MARKET SIZE, BY DETECTION DEVICES, 2018-2032 (USD MILLION)
TABLE 215. EUROPEAN UNION BIODEFENSE MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 216. EUROPEAN UNION BIODEFENSE MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 217. EUROPEAN UNION BIODEFENSE MARKET SIZE, BY PATHOGEN TYPE, 2018-2032 (USD MILLION)
TABLE 218. EUROPEAN UNION BIODEFENSE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 219. EUROPEAN UNION BIODEFENSE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 220. EUROPEAN UNION BIODEFENSE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 221. EUROPEAN UNION BIODEFENSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 222. BRICS BIODEFENSE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 223. BRICS BIODEFENSE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 224. BRICS BIODEFENSE MARKET SIZE, BY DECONTAMINATION PRODUCTS, 2018-2032 (USD MILLION)
TABLE 225. BRICS BIODEFENSE MARKET SIZE, BY DETECTION DEVICES, 2018-2032 (USD MILLION)
TABLE 226. BRICS BIODEFENSE MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 227. BRICS BIODEFENSE MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 228. BRICS BIODEFENSE MARKET SIZE, BY PATHOGEN TYPE, 2018-2032 (USD MILLION)
TABLE 229. BRICS BIODEFENSE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 230. BRICS BIODEFENSE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 231. BRICS BIODEFENSE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 232. BRICS BIODEFENSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 233. G7 BIODEFENSE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 234. G7 BIODEFENSE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 235. G7 BIODEFENSE MARKET SIZE, BY DECONTAMINATION PRODUCTS, 2018-2032 (USD MILLION)
TABLE 236. G7 BIODEFENSE MARKET SIZE, BY DETECTION DEVICES, 2018-2032 (USD MILLION)
TABLE 237. G7 BIODEFENSE MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 238. G7 BIODEFENSE MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 239. G7 BIODEFENSE MARKET SIZE, BY PATHOGEN TYPE, 2018-2032 (USD MILLION)
TABLE 240. G7 BIODEFENSE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 241. G7 BIODEFENSE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 242. G7 BIODEFENSE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 243. G7 BIODEFENSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 244. NATO BIODEFENSE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 245. NATO BIODEFENSE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 246. NATO BIODEFENSE MARKET SIZE, BY DECONTAMINATION PRODUCTS, 2018-2032 (USD MILLION)
TABLE 247. NATO BIODEFENSE MARKET SIZE, BY DETECTION DEVICES, 2018-2032 (USD MILLION)
TABLE 248. NATO BIODEFENSE MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 249. NATO BIODEFENSE MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 250. NATO BIODEFENSE MARKET SIZE, BY PATHOGEN TYPE, 2018-2032 (USD MILLION)
TABLE 251. NATO BIODEFENSE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 252. NATO BIODEFENSE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 253. NATO BIODEFENSE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 254. NATO BIODEFENSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 255. GLOBAL BIODEFENSE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 256. UNITED STATES BIODEFENSE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 257. UNITED STATES BIODEFENSE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 258. UNITED STATES BIODEFENSE MARKET SIZE, BY DECONTAMINATION PRODUCTS, 2018-2032 (USD MILLION)
TABLE 259. UNITED STATES BIODEFENSE MARKET SIZE, BY DETECTION DEVICES, 2018-2032 (USD MILLION)
TABLE 260. UNITED STATES BIODEFENSE MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 261. UNITED STATES BIODEFENSE MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 262. UNITED STATES BIODEFENSE MARKET SIZE, BY PATHOGEN TYPE, 2018-2032 (USD MILLION)
TABLE 263. UNITED STATES BIODEFENSE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 264. UNITED STATES BIODEFENSE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 265. UNITED STATES BIODEFENSE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 266. UNITED STATES BIODEFENSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 267. CHINA BIODEFENSE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 268. CHINA BIODEFENSE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 269. CHINA BIODEFENSE MARKET SIZE, BY DECONTAMINATION PRODUCTS, 2018-2032 (USD MILLION)
TABLE 270. CHINA BIODEFENSE MARKET SIZE, BY DETECTION DEVICES, 2018-2032 (USD MILLION)
TABLE 271. CHINA BIODEFENSE MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 272. CHINA BIODEFENSE MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 273. CHINA BIODEFENSE MARKET SIZE, BY PATHOGEN TYPE, 2018-2032 (USD MILLION)
TABLE 274. CHINA BIODEFENSE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 275. CHINA BIODEFENSE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 276. CHINA BIODEFENSE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 277. CHINA BIODEFENSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Biodefense market report include:
  • Abbott Laboratories
  • Alnylam Pharmaceuticals, Inc.
  • Altimmune, Inc.
  • Bavarian Nordic A/S
  • Bio-Rad Laboratories
  • Biofourmis Singapore Pte. Ltd.
  • Cleveland Biolabs Inc.
  • Dynavax Technologies Corporation
  • DynPort Vaccine Company LLC
  • Ecolab Inc.
  • Elusys Therapeutics, Inc.
  • Emergent BioSolutions Inc.
  • Ichor Medical Systems
  • Lucentix SA
  • Luminex Corporation
  • Nova Biomedical Corporation
  • QIAGEN N.V.
  • SD BIOSENSOR
  • Siemens Healthcare
  • Siga Technologies, Inc.
  • Strados Labs
  • Thermo Fisher Scientific
  • Xoma Corporation

Table Information

Report AttributeDetails
No. of Pages180
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 24.97 Billion
Forecasted Market Value ( USD ) by 2032 $ 49.09 Billion
Compound Annual Growth Rate11.6%
Regions CoveredGlobal
No. of Companies Mentioned24

Related Topics

Related Reports

Biodefense - Global Strategic Business Report - Product Image

Biodefense - Global Strategic Business Report

  • Report
  • 115 Pages
  • Global
From
Biodefense Market by Technology, Product, Application, and Region - Global Forecast to 2030 - Product Image

Biodefense Market by Technology, Product, Application, and Region - Global Forecast to 2030

  • Report
  • 218 Pages
  • Global
From
Biodefense Market Report 2025 - Product Image

Biodefense Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Biochemical Defense Market Report 2026 - Product Image

Biochemical Defense Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Bio-Detection - Global Strategic Business Report - Product Image

Bio-Detection - Global Strategic Business Report

  • Report
  • 281 Pages
  • Global
From

About the Biodefense Market

The Biodefense market is a sector of the biotechnology industry that focuses on the development of products and services to protect against biological threats. This includes the development of vaccines, diagnostics, and treatments for infectious diseases, as well as the development of countermeasures to protect against bioterrorism. Biodefense products are designed to protect against a wide range of biological agents, including bacteria, viruses, and toxins. The Biodefense market is driven by the need to protect against the increasing threat of biological agents, as well as the need to develop treatments for existing and emerging infectious diseases. Governments, healthcare organizations, and private companies are investing in the development of biodefense products and services. Some of the major companies in the Biodefense market include Emergent BioSolutions, GlaxoSmithKline, Johnson & Johnson, Merck, Novavax, Pfizer, and Sanofi. These companies are developing a range of products and services to protect against biological threats, including vaccines, diagnostics, and treatments. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.